This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Journalology/ Peer Review/ Authorship  • Neurology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Roger N. Rosenberg, MD, Editor

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As the Editor of the Archives of Neurology, I am writing to inquire about your article titled "Cross-reactive T-Cell Receptors in Tumor and Paraneoplastic Target Tissue," which was published in the May 2009 issue of the Archives.¹

You recently wrote to the Editor of The Journal of the Neurological Sciences (JNS) that:

"I wanted to let you know that we have used biological material from the patient described in full detail in our paper 10974 in another paper just appearing in Arch Neurol (attached). In that paper we report CDR3 spectratyping data of tumor and CNS. However, in the "methods" section, we very briefly scratch the clinical scenario so readers understand the CDR3 data presented. We have always felt that this would not be a problem."

AUTHOR INFORMATION



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?